Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Menin-MLL1 complex is a protein-protein interaction between menin, a scaffold protein encoded by the MEN1 gene, and Mixed Lineage Leukemia 1 (MLL1), a histone H3 lysine 4 (H3K4) methyltransferase that functions as a transcriptional co-activator. Menin tethers MLL1 to chromatin promoters, facilitating assembly of the MLL1 core complex (including WDR5, RbBP5, Ash2L, DPY-30) via the MLL1 Win motif binding to WDR5, which enables mono-, di-, and trimethylation of H3K4 to maintain active gene expression, such as Hox genes. MLL1 is proteolytically processed into MLL-N and MLL-C fragments that reassociate, with domains like CXXC for DNA binding, SET for methyltransferase activity, and motifs for cofactor interactions. The interaction involves MLL1's N-terminal menin-binding motifs (MBM1: MLL4-15, MBM2: MLL23-43) binding menin's deep pocket with high affinity (Kd=6.8 nM). This complex drives leukemogenesis in MLL1-translocated acute leukemias and solid tumors, acting as a therapeutic target for small-molecule inhibitors that block the interface.[1][2][3][5]
Inhibition of menin-MLL1 protein-protein interaction, Disruption of H3K4 methylation, Prevention of MLL1 core complex assembly
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Menin-MLL1 complex.